SUMMARY  

• BALVERSA is not commercially available as a solution or suspension.
• Data from pharmacokinetic and pharmacodynamic studies of crushing or splitting BALVERSA tablets for administration are not available.
• The company cannot support crushing or splitting BALVERSA tablets for administration.
• The company cannot support any practices, procedures, or dosage administration techniques that deviate from approved product labeling.

Literature Search

A literature search of MEDLINE^®, Embase^®, BIOSIS Previews^®, and Derwent Drug File (and/or other resources, including internal/external databases) was conducted on 04 November 2024.